Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,219 hedge funds and large institutions have $60B invested in Celgene Corp in 2016 Q2 according to their latest regulatory filings, with 83 funds opening new positions, 503 increasing their positions, 476 reducing their positions, and 75 closing their positions.
11% more first-time investments, than exits
New positions opened: 83 | Existing positions closed: 75
6% more repeat investments, than reductions
Existing positions increased: 503 | Existing positions reduced: 476
0% less funds holding
Funds holding: 1,225 → 1,219 (-6)
2% less call options, than puts
Call options by funds: $963M | Put options by funds: $983M
3% less capital invested
Capital invested by funds: $61.8B → $60B (-$1.81B)
13% less funds holding in top 10
Funds holding in top 10: 85 → 74 (-11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carmignac Gestion
Paris,
France
|
+$220M |
| 2 |
Lazard Asset Management
New York
|
+$129M |
| 3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$109M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$104M |
| 5 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$96.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$428M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$315M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$189M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$179M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$148M |
CELG Hedge Fund Activity: Q2 2016 in Review
1,219 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q2 2016, worth a combined $60B — down 2.9% from $61.8B a quarter earlier.
Buyers outnumbered sellers: 83 funds opened new CELG positions and 75 closed out — a net gain of 8 holders — while 503 added to existing stakes and 476 trimmed.
The largest buyer was Carmignac Gestion, adding an estimated $220M. The largest seller was JP Morgan Chase, cutting an estimated $428M.
- 1,219 institutional investors held Celgene Corp (CELG) as of Q2 2016, down from 1,225 in Q1 2016.
- Funds reported $60B of Celgene Corp stock for Q2 2016, down 2.9% quarter-over-quarter.
- 83 funds opened new Celgene Corp positions in Q2 2016 and 75 closed out, a net change of +8 holders.
- The largest Celgene Corp buyer in Q2 2016 was Carmignac Gestion, an estimated $220M added.
- The largest Celgene Corp seller in Q2 2016 was JP Morgan Chase, an estimated $428M sold.
Based on aggregated 13F filings for Q2 2016.